Tech Journal of Colorado
SEE OTHER BRANDS

Get your fresh news on science and technology in Colorado

Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

Press releases published on May 8, 2025

FOREWARN to Provide Identity Verification Services to NEXUS Association of REALTORS® to Promote Agent Safety

FOREWARN to Provide Identity Verification Services to NEXUS Association of REALTORS® to Promote Agent Safety

BOCA RATON, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that NEXUS Association of REALTORS® (“NEXUS”) will …

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference

Norwood, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fireside chat and one-on- …

Angry Shrimp Media Now ‘Go-To’ Growth Engine Builder for Founders and CEOs Scaling Smarter

Angry Shrimp Media Now ‘Go-To’ Growth Engine Builder for Founders and CEOs Scaling Smarter

Cape Coral, Florida, May 08, 2025 (GLOBE NEWSWIRE) -- Angry Shrimp Media is redefining what smart scale looks like for today’s B2B leaders. Built for SaaS founders …

RAPT Therapeutics Reports First Quarter 2025 Financial Results

RAPT Therapeutics Reports First Quarter 2025 Financial Results

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel …

Cassava Reports Q1 2025 Financials Results, Provides Business Update

Cassava Reports Q1 2025 Financials Results, Provides Business Update

License agreement and recent leadership appointments position Cassava to advance development of simufilam in TSC-related epilepsy $117.3 Million in Cash and Cash Equivalents at March 31, 2025 AUSTIN, Texas, May 08, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences …

Core Molding Technologies Reports Fiscal 2025 First Quarter Results

Core Molding Technologies Reports Fiscal 2025 First Quarter Results

COLUMBUS, Ohio, May 08, 2025 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing in molded structural products, principally in building …

VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update

VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update

Repibresib gel (VYN201) Phase 2b vitiligo top-line results expected in mid-2025 Expected cash runway into 2H 2026 BRIDGEWATER, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage …

Glimpact Launches Global Impact Score – A Free Online Tool to Measure and Reduce the Environmental Footprint of Apparel, Revealing a New Vision of the Challenges of the Fashion Industry’s Ecological Transition

Glimpact Launches Global Impact Score – A Free Online Tool to Measure and Reduce the Environmental Footprint of Apparel, Revealing a New Vision of the Challenges of the Fashion Industry’s Ecological Transition

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Glimpact, the first platform for analyzing the overall systemic environmental impact of products and organizations, today launched Global Impact Score, North America’s first publicly accessible online tool to …

Cue Biopharma to Host Virtual Investor Event on May 15, 2025

Cue Biopharma to Host Virtual Investor Event on May 15, 2025

Mobilizing the Immune System: Cue Biopharma's Novel Biologics Portfolio Event Virtual Event will Feature Key Opinion Leaders Richard DiPaolo, PhD, and Andrew Cope, MD, PhD BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a …

Infinidat Wins 2025 Global InfoSec Awards for Cyber Resilience, Cyber Storage, and Ransomware Recovery from Cyber Defense Magazine

Infinidat Wins 2025 Global InfoSec Awards for Cyber Resilience, Cyber Storage, and Ransomware Recovery from Cyber Defense Magazine

WALTHAM, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Infinidat, a leading provider of enterprise storage solutions, today announced that the company has won three Global InfoSec Awards from Cyber Defense Magazine, a leading information security magazine. The …

Xunlei Limited Schedules 2025 Unaudited First Quarter Earnings Release on May 15, 2025

Xunlei Limited Schedules 2025 Unaudited First Quarter Earnings Release on May 15, 2025

SHENZHEN, China, May 08, 2025 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced that it plans to release its unaudited financial …

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research …

Remote Monitoring and Control Provider Acorn’s Q1’25 EPS Rose to $0.19 vs. $0.03 on 45% Higher Revenue; Investor Call Today at 11am ET

Remote Monitoring and Control Provider Acorn’s Q1’25 EPS Rose to $0.19 vs. $0.03 on 45% Higher Revenue; Investor Call Today at 11am ET

WILMINGTON, Del., May 08, 2025 (GLOBE NEWSWIRE) -- Acorn Energy, Inc. (OTCQB: ACFN), a provider of remote monitoring and control solutions for backup generators, gas pipelines and other critical infrastructure assets, announced results for its first …

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

Record First Quarter MACI Revenue of $46.3 Million and First Quarter Total Revenue of $52.6 Million Approximately 400 MACI Arthro Surgeons Trained to Date, with Year-to-Date Biopsy Growth Over 30% for Trained Surgeons Second Quarter Total Revenue and MACI …

OrganOx Announces Second Private Placement Closing, Investments by Intuitive Ventures and Terumo Ventures

OrganOx Announces Second Private Placement Closing, Investments by Intuitive Ventures and Terumo Ventures

OXFORD, England and MADISON, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, completed a second closing of its private placement with investments from Intuitive Ventures, Terumo Ventures, and Piper Heartland …

Cognition Therapeutics Reports Topline Results Showing Oral Zervimesine (CT1812) Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy

Cognition Therapeutics Reports Topline Results Showing Oral Zervimesine (CT1812) Reduced Lesion Growth in Phase 2 Study in Geographic Atrophy

Zervimesine treatment slowed the rate of GA lesion growth by 28.6% compared to placebo Observed GA lesion area was reduced by 28.2% at 18 months compared to placebo Dry AMD results validate zervimesine’s potential across degenerative disease indications …

Kamari Pharma Announces Presentations at the 82nd Annual Meeting of the Society for Investigative Dermatology and the International Pachyonychia Congenita Consortium Symposium

Kamari Pharma Announces Presentations at the 82nd Annual Meeting of the Society for Investigative Dermatology and the International Pachyonychia Congenita Consortium Symposium

Preclinical results presented demonstrate KM-023 is a highly effective and selective oral TRPV3 inhibitor KM-023 normalized cells proliferation and differentiation in 3D pachyonychia congenita skin model and significantly reduced itch behavior and …

CoreCard Corporation Reports First Quarter 2025 Results

CoreCard Corporation Reports First Quarter 2025 Results

NORCROSS, Ga., May 08, 2025 (GLOBE NEWSWIRE) -- CoreCard Corporation (NYSE: CCRD) (“CoreCard” or the “Company”), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, …

Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™

Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™

GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced the …

Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress

On track to complete enrollment of the global Phase 3 HAELO study in hereditary angioedema (HAE) in the third quarter of 2025 Dosed first patient in the global Phase 3 MAGNITUDE-2 study evaluating nexiguran ziclumeran (nex-z) in patients with hereditary …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service